Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 ValmAla) p53
1998

Effects of Mutated p53 on Melanoma Growth

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): S Rauth, A Green, J Kichina, A Shilkaitis

Primary Institution: University of Illinois at Chicago

Hypothesis

Mutated p53 (143 Val-Ala) can suppress tumorigenic and metastatic potentials of human melanoma cell lines.

Conclusion

Mutated p53 inhibits melanoma growth and progression in vivo.

Supporting Evidence

  • Mutated p53 expression inhibited tumor growth in 50% of cases.
  • Mutated p53 transfectants produced significantly slower growing non-metastatic tumors.
  • Addition of Matrigel abrogated the inhibitory effect of mutated p53 on tumor growth.

Takeaway

Scientists studied how a mutated version of a protein called p53 affects melanoma, a type of skin cancer, and found that it can slow down tumor growth.

Methodology

The study involved transfecting human melanoma cell lines with wild-type and mutated p53 and assessing tumor growth and metastasis in athymic mice.

Limitations

The study did not explore other p53 mutations or their effects on melanoma.

Participant Demographics

Human melanoma cell lines derived from patients with metastatic melanoma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication